Previous close | 201.48 |
Open | 202.25 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 800 |
Day's range | 200.67 - 203.89 |
52-week range | 179.59 - 234.09 |
Volume | |
Avg. volume | 744,403 |
Market cap | 17.083B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 46.90 |
EPS (TTM) | 4.33 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | 2.88 (1.42%) |
Ex-dividend date | 28 May 2024 |
1y target est | 246.13 |
Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.